Related Experiment Videos

Use of salbutamol powder in childhood asthma

Insights

Salbutamol powder delivered via rotahaler is effective for children aged 3 and older with asthma. This study found it as effective as traditional salbutamol aerosol for daily asthma symptom management.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Pharmacology

Background:

  • Asthma is a common chronic respiratory disease in children.
  • Effective delivery of bronchodilators is crucial for asthma management.
  • Different inhaler devices exist, with varying suitability for young children.

Purpose of the Study:

  • To compare the efficacy of salbutamol powder versus salbutamol aerosol in asthmatic children.
  • To assess the usability and effectiveness of the rotahaler device in young asthmatic children.
  • To evaluate salbutamol powder's impact on peak expiratory flow rate (PEFR) in pediatric asthma patients.

Main Methods:

  • A 6-week study involving 31 asthmatic children.
  • Daily administration of salbutamol powder via rotahaler and salbutamol aerosol.
  • Measurement of peak expiratory flow rate (PEFR) to assess bronchodilator effectiveness.

Main Results:

  • Salbutamol powder demonstrated comparable efficacy to salbutamol aerosol in older asthmatic children.
  • The rotahaler device was successfully used by children as young as 3 years old.
  • Salbutamol powder effectively improved PEFR in this young pediatric age group.

Conclusions:

  • Salbutamol powder delivered via rotahaler is a viable and effective treatment option for pediatric asthma.
  • The rotahaler is suitable for children aged 3 years and above for delivering salbutamol.
  • This delivery method offers an effective alternative for daily asthma symptom control in young asthmatic patients.

Related Concept Videos